CollabRx and OncoDNA Partner in Molecular Diagnostics
April 04, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, April 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium...
CollabRx Forms Pan Cancer Molecular Oncology Editorial Board
March 26, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, March 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the...
CollabRx(TM) and Projects In Knowledge(R) Partner to Provide Decision Support Tools to Oncologists
March 04, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, March 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Projects In Knowledge,...
CollabRx Forms Editorial Board for Prostate Cancer
February 19, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 19, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the formation of an editorial board for prostate cancer to be led by E. David Crawford, M.D. who will...
CollabRx Reports Q3 Fiscal Year 2013 Financial Results
February 12, 2013 16:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the Third Quarter Fiscal Year 2013, which ended December 31,...
CollabRx Releases Second Generation Lung Cancer Clinical Decision Support Tool for Oncologists
February 07, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 7, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the release of a new version of its Therapy Finder™application ("app") for lung cancer. The lung...
CollabRx Schedules Q3 Fiscal Year 2013 Financial Conference Call and Business Update
February 05, 2013 07:01 ET
|
CollabRx, Inc.
SAN FRANCISCO, Feb. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February...